Literature DB >> 29532436

Serial evaluation of myocardial function using the myocardial performance index in Kawasaki disease.

Eun Song Song1, Somy Yoon2, Joo Hyun Cho1, Eun Mi Yang1, Hwa Jin Cho1, Young Youn Choi1, Jae Sook Ma3, Gwang Hyeon Eom4, Young Kuk Cho1.   

Abstract

BACKGROUND: Kawasaki disease (KD) is known as systemic vasculitis, and more than half of the patients with KD have myocarditis, which can induce ventricular dysfunction. In this study, we evaluate left ventricular (LV) dysfunction in patients with KD based on the myocardial performance index (MPI) using pulse Doppler (PD) and tissue Doppler imaging (TDI), from the acute to convalescent phases.
METHODS: We retrospectively studied 89 children diagnosed with KD from January 2010 to August 2012. We assessed the presence of coronary artery lesions (CALs) and the LV ejection fraction, PD-MPI, and TDI-MPI at diagnosis, and 2, 14, and 56 days after intravenous immunoglobulin (IVIG) treatment. We enrolled 70 healthy children as a control group.
RESULTS: The ejection fraction in patients with KD at diagnosis (67.3 ± 0.9%) was lower than that in the control group (69.8 ± 0.8%, P = 0.035), and the LV TDI-MPIs for patients with KD at diagnosis (0.49 ± 0.01) and 2 days after IVIG treatment (0.48 ± 0.01) were higher than those in the control group (0.45 ± 0.01, P = 0.002, P = 0.033, respectively). No significant differences were found in the LV dysfunction between the patients with complete and incomplete KD. Septal TDI-MPIs in patients with KD with CAL at diagnosis (0.52 ± 0.02) were higher than those in patients with KD without CAL (0.47 ± 0.01, P = 0.019).
CONCLUSIONS: Transient LV dysfunction occurred in patients with complete and incomplete KD in the acute stage. In patients with KD with CAL at diagnosis, the LV dysfunction was more prominent. The PD-MPI and TDI-MPI are useful parameters for assessing LV function in patients with KD.

Entities:  

Keywords:  Kawasaki disease; Myocardial function; Myocardial performance index; Tissue Doppler imaging

Mesh:

Substances:

Year:  2018        PMID: 29532436     DOI: 10.1007/s12519-018-0142-x

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  36 in total

1.  Abnormal myocardial mechanics in Kawasaki disease: rapid response to gamma-globulin.

Authors:  A M Moran; J W Newburger; S P Sanders; I A Parness; P J Spevak; J C Burns; S D Colan
Journal:  Am Heart J       Date:  2000-02       Impact factor: 4.749

Review 2.  Diagnosis and therapy of Kawasaki disease in children.

Authors:  A S Dajani; K A Taubert; M A Gerber; S T Shulman; P Ferrieri; M Freed; M Takahashi; F Z Bierman; A W Karchmer; W Wilson
Journal:  Circulation       Date:  1993-05       Impact factor: 29.690

3.  A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography.

Authors:  M A Quinones; A D Waggoner; L A Reduto; J G Nelson; J B Young; W L Winters; L G Ribeiro; R R Miller
Journal:  Circulation       Date:  1981-10       Impact factor: 29.690

4.  [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children].

Authors:  T Kawasaki
Journal:  Arerugi       Date:  1967-03

5.  Incomplete clinical manifestation as a risk factor for coronary artery abnormalities in Kawasaki disease: a meta-analysis.

Authors:  Kee-Soo Ha; GiYoung Jang; JungHwa Lee; KwangChul Lee; YoungSook Hong; ChangSung Son; JooWon Lee
Journal:  Eur J Pediatr       Date:  2012-11-16       Impact factor: 3.183

6.  Evaluation of myocardial function using the Tei index in patients with Kawasaki disease.

Authors:  Gholamhossein Ajami; Mohammad Borzouee; Hamid Amoozgar; Feridoon Ashnaee; Sara Kashef; Mir Sabina Nesar; Mir Soleh Nesar
Journal:  Cardiol Young       Date:  2009-12-18       Impact factor: 1.093

7.  Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  A S Dajani; K A Taubert; M Takahashi; F Z Bierman; M D Freed; P Ferrieri; M Gerber; S T Shulman; A W Karchmer; W Wilson
Journal:  Circulation       Date:  1994-02       Impact factor: 29.690

8.  Echocardiographic and electrocardiographic trends in children with acute Kawasaki disease.

Authors:  Matthew A Crystal; Sumeet K Syan; Rae S M Yeung; Anne I Dipchand; Brian W McCrindle
Journal:  Can J Cardiol       Date:  2008-10       Impact factor: 5.223

9.  Role of age on transmitral flow velocity patterns in assessing left ventricular diastolic function in normal infants and children.

Authors:  K Harada; T Suzuki; M Tamura; T Ito; Y Takahashi; K Shimada; G Takada
Journal:  Am J Cardiol       Date:  1995-09-01       Impact factor: 2.778

10.  Cardiac biopsy of Kawasaki disease.

Authors:  C Yutani; S Go; T Kamiya; O Hirose; H Misawa; H Maeda; T Kozuka; S Onishi
Journal:  Arch Pathol Lab Med       Date:  1981-09       Impact factor: 5.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.